{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:45Z","timestamp":1786979625801,"version":"build-2736575974"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00120-022-01807-6","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T14:23:17Z","timestamp":1647958997000},"page":"959-970","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hat eine Ventilversorgung Vorteile bei der katheterassoziierten Lebensqualit\u00e4t?","Are there benefits for catheter valves for catheter-associated quality of life?"],"prefix":"10.1007","volume":"61","author":[{"given":"Andreas","family":"Wiedemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gedding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Manseck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kirschner-Hermanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Liebald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Linn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Eisenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bannowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wirz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Brammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-J.","family":"Heppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"1807_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/a-1011-4919","volume":"51","author":"A Wiedemann","year":"2020","unstructured":"Wiedemann\u00a0A, Becher\u00a0K, Bojack\u00a0B, Drews\u00a0C, Ege\u00a0S et\u00a0al (2020) S2e guideline \u201eUrinary incontinence in geriatric patients\u201c: a\u00a0summary. Aktuelle Urol 51:65\u201370","journal-title":"Aktuelle Urol"},{"issue":"1","key":"1807_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00120-021-01642-1","volume":"61","author":"A Wiedemann","year":"2022","unstructured":"Wiedemann\u00a0A, Gedding\u00a0C, Heese\u00a0M, Stein\u00a0J, Manseck\u00a0A et\u00a0al (2022) Quality of life for wearers of a\u00a0suprapubic or transurethral bladder catheter as lifelong permanent care. Urologe\u00a0A 61(1):18\u201330. https:\/\/doi.org\/10.1007\/s00120-021-01642-1","journal-title":"Urologe\u00a0A"},{"key":"1807_CR3","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/nau.20865","volume":"29","author":"MH Wilde","year":"2010","unstructured":"Wilde\u00a0MH, Getliffe\u00a0K, Brasch\u00a0J, McMahon\u00a0J, Anson\u00a0E, Tu\u00a0X (2010) A new urinary catheter-related quality of life instrument for adults. Neurourol Urodyn 29:1282\u20131285","journal-title":"Neurourol Urodyn"},{"key":"1807_CR4","first-page":"83","volume":"117","author":"J Kranz","year":"2020","unstructured":"Kranz\u00a0J, Schmidt\u00a0S, Wagenlehner\u00a0F, Schneidewind\u00a0L (2020) Catheter-associated urinary tract infections in adult patients. Dtsch Arztebl Int 117:83\u201388","journal-title":"Dtsch Arztebl Int"},{"key":"1807_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1682\/JRRD.2007.07.0112","volume":"45","author":"BG Orris","year":"2008","unstructured":"Orris\u00a0BG, Jahoda\u00a0AE, Walter\u00a0JS, Nemchausky\u00a0BN, Wurzel\u00a0R et al (2008) A 24-hour feasibility study of intraurethral valved catheter for bladder management in males with spinal cord injury. J\u00a0Rehabil Res Dev 45:639\u2013646","journal-title":"J Rehabil Res Dev"},{"key":"1807_CR6","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1469-0691.2004.00936.x","volume":"10","author":"E Bouza","year":"2004","unstructured":"Bouza\u00a0E, San Juan\u00a0R, Munoz\u00a0P, Pascau\u00a0J, Voss\u00a0A et al (2004) A European perspective on intravascular catheter-related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study). Clin Microbiol Infect 10:838\u2013842","journal-title":"Clin Microbiol Infect"},{"key":"1807_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000442847","volume":"9","author":"G Virdi","year":"2016","unstructured":"Virdi\u00a0G, Hendry\u00a0D (2016) Urinary retention: catheter drainage bag or catheter valve? Curr Urol 9:28\u201330","journal-title":"Curr Urol"},{"key":"1807_CR8","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s00103-014-1966-8","volume":"57","author":"NA Lahmann","year":"2014","unstructured":"Lahmann\u00a0NA, Heinze\u00a0C, Rommel\u00a0A (2014) Falls in German hospitals and nursing homes 2006\u20132013. Frequencies, injuries, risk assessment, and preventive measures. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57:650\u2013659","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-022-01807-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-022-01807-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-022-01807-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T10:02:56Z","timestamp":1661767376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-022-01807-6"}},"subtitle":["Ergebnisse einer Untersuchung an 427\u00a0Kathetertr\u00e4gern in lebenslanger Indikation","Results of an investigation in 427\u00a0catheter wearers with life-long indication"],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1807"],"URL":"https:\/\/doi.org\/10.1007\/s00120-022-01807-6","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"11 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"<b>A.\u00a0Wiedemann<\/b> geht einer Berater- bzw. Gutachtert\u00e4tigkeit sowie einer Mitarbeit in einem Wissenschaftlichen Beirat (advisory board) f\u00fcr Dr. Pfleger, Pfizer Pharma und Omega Pharma nach. Des Weiteren wurden Schulungs- und Vortragst\u00e4tigkeiten f\u00fcr AMS Deutschland, Astellas, Berlin Chemie, Boston Scientific, Dr. Pfleger, Ipsen, Jansen, Meda, Omega Pharma, Acticor, Aristo bezahlt und es bestehen Forschungsvorhaben zur Durchf\u00fchrung klinischer Studien f\u00fcr Scientific, Dr. Pfleger, Paul-Kuth-Stiftung Deutsche Bank. Indirekte Interessenkonflikte bestehen bei DGU, DGG, DKG und NRW-GU. <b>J.\u00a0Stein<\/b> geht einer Berater- bzw. Gutachtert\u00e4tigkeit sowie einer Mitarbeit in einem Wissenschaftlichen Beirat (advisory board) f\u00fcr Advisory Board der Firma Bayer nach. Des Weiteren wurden Schulungs- und Vortragst\u00e4tigkeiten f\u00fcr Medac, Lilly bezahlt und es bestehen Forschungsvorhaben zur Durchf\u00fchrung klinischer Studien f\u00fcr Medac, Lilly, Jenapharm, Boston Scientific, Pfizer, Takeda, Astellas, Janssen, Sanofi, Dr. Pfleger, Gruenenthal, MSD, Bristol-Myers-Squibb. <b>A.\u00a0Manseck<\/b> geht einer Berater- bzw. Gutachtert\u00e4tigkeit f\u00fcr die Bayrische Landes\u00e4rztekammer, Landesdirektion Sachsen und OnkoZert nach. Des Weiteren wurden Schulungs- und Vortragst\u00e4tigkeiten f\u00fcr DGU, BvDU und das Garmische Assistentenseminar bezahlt und es bestehen indirekte Interessenkonflikte bei der Geriatrischen Urologie, der robotischen Urologie, DGU, der Bayerischen Urologenvereinigung, der Roboter-Assistierten Urologie, dem F\u00f6rderverein Krebskranker der Region Ingolstadt e.\u202fV. <b>R.\u00a0Kirschner-Hermanns<\/b> ist CEO und Founder der MEC\/\/ABC GmbH und Medical Care and Product Development in Aachen, Bonn und Cologne. Des Weiteren wurden Schulungs- und Vortragst\u00e4tigkeiten f\u00fcr Repha GmbH bezahlt. Es bestehen Forschungsvorhaben zur Durchf\u00fchrung klinischer Studien f\u00fcr Angocei Antinfekt N und eine Schulung f\u00fcr Laborie des F\u00f6rdervereins Kontinenzf\u00f6rderung und Kontinenzaufkl\u00e4rung e.V. Aachen sowie indirekte Interessenkonflikte bei DAU, DGU, DGG. <b>C.\u00a0Linn\u00e9<\/b> geht einer Berater- bzw. Gutachtert\u00e4tigkeit f\u00fcr Apogepha Pharma GmbH sowie einer Mitarbeit in einem Wissenschaftlichen Beirat (advisory board) f\u00fcr Apogepha GmbH, Janssen Cilag, MSD, BMS nach. Des Weiteren wurden Schulungs- und Vortragst\u00e4tigkeiten f\u00fcr MSD, Ratiopharm, Ipsen, Janssen, Apogepha, Pfizer und BMS bezahlt und es bestehen indirekte Interessenkonflikte bei DGU. <b>T.\u00a0Liebald<\/b> geht einer Berater- bzw. Gutachtert\u00e4tigkeit sowie einer Mitarbeit in einem Wissenschaftlichen Beirat (advisory board) f\u00fcr Apogepha, Sanofi, MSD und Astellas nach. Es bestehen indirekte Interessenkonflikte bei DGU. <b>V.\u00a0Moll<\/b> geht einer Berater- bzw. Gutachtert\u00e4tigkeit f\u00fcr Recordati nach. Des Weiteren wurden Schulungs- und Vortragst\u00e4tigkeiten f\u00fcr Recordati, Aristo und Medac bezahlt. <b>J.\u00a0Salem<\/b> geht einer Berater- bzw. Gutachtert\u00e4tigkeit f\u00fcr Lisa Laser, Ambu GmbH und Purenum nach. Des Weiteren wurden Schulungs- und Vortragst\u00e4tigkeiten f\u00fcr Olympus und Omega Pharma bezahlt und es bestehen Forschungsvorhaben zur Durchf\u00fchrung klinischer Studien f\u00fcr Ambu GmbH. <b>A.\u00a0Eisenhardt<\/b> wurden Schulungs- und Vortragst\u00e4tigkeiten f\u00fcr Takeda, Apogepha, Medac, Janssen-Cilag und Ipsen bezahlt. <b>S.\u00a0Wirz<\/b> geht einer Berater- bzw. Gutachtert\u00e4tigkeit sowie einer Mitarbeit in einem Wissenschaftlichen Beirat (advisory board) f\u00fcr Dr. Pfleger, Stada Pharma, KyowaKirin und Sandoz\/Hexal nach. Des Weiteren wurden Schulungs- und Vortragst\u00e4tigkeiten f\u00fcr KyowaKirin, Gr\u00fcnenthal, Dr. Kade\/Besin, Mundipharma China bezahlt. <b>H.-J.\u00a0Heppner<\/b> geht einer Berater- bzw. Gutachtert\u00e4tigkeit f\u00fcr Astellas Pharma und Pfizer Pharma nach. Des Weiteren wurden Schulungs- und Vortragst\u00e4tigkeiten f\u00fcr Pfizer Pharma, Bayer Health Care, Mundipharma, Astellas Pharma, MSD, BL\u00c4K, AO Trauma Europa bezahlt und es bestehen Forschungsvorhaben zur Durchf\u00fchrung klinischer Studien f\u00fcr ThermoScience, Forschungskolleg Geriatrie der Robert-Bosch-Stiftung, Wissenschaftsforum Geriatrie, Infectopharm und GBA Innovationsfonds. <b>A.\u00a0Mourad, C.\u00a0Gedding, A.\u00a0Schorn, A.\u00a0Wagner, U.\u00a0Unger, A.\u00a0Bannowsky<\/b> und <b>E.\u00a0Brammen<\/b> geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Alle beschriebenen Untersuchungen am Menschen wurden mit Zustimmung der zust\u00e4ndigen Ethik-Kommission, im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt. Von allen beteiligten Patienten liegt eine Einverst\u00e4ndniserkl\u00e4rung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}